Michel Bédard

CEO

Michel Bédard is a technology entrepreneur with more than 20 years experience in photonic measurement instruments. In 1991, Mr. Bédard co-founded Nortech Fibronic, a leading fiberoptic sensor and test equipment company that is now a part of EXFO Electro-optical Engineering Inc. (NASDAQ: EXFO; TSX: EXF). As CEO and Vice President of Research and Development for Nortech Fibronic, Mr. Bédard led the development of innovative photonic instruments and developed OEM partnerships with global companies, such as WWG (now part of Ideal Industries), Microtest (now part of Fluke Networks) and Urologix.

Mr. Bédard holds a Bachelor’s Degree in Electrical Engineering and a Graduate Diploma in Business Administration from Université Laval. Mr. Bédard has been a member of the Ordre des ingénieurs du Québec since 1988. He won the Quebec Entrepreneur Award in 1991 for the best business plan and was President of the Québec Optics and Photonics Association from 1999 to 2001.

Dany Nolet

Vice President, Research and Development

Dany Nolet is an industry veteran with nearly 20 years experience in engineering, research and development, and product marketing. As former Director of Research and Development and Product Marketing Manager at Nortech Fibronic, Mr. Nolet developed handheld photonic devices, including OEM products for Microtest (now part of Fluke Networks) and WWG (now part of Ideal Industries) and a medical device for Urologix. From 1990 to 1996, he designed high-reliability electronic systems for a supplier of mass transit systems to Bombardier with end customers such as NYCTA, MBTA and NJ Transit authorities.

Mr. Nolet holds a Bachelor’s Degree in Electrical Engineering from Université Laval and a Master's Degree in Project Management from Université du Québec à Trois-Rivières. Mr. Nolet has been a member of the Ordre des ingénieurs du Québec since 1990.

Robert Oringer

Marketing Advisor

Robert Oringer is Co-Chairman and a Board Director of AMG Medical (Montreal, Canada). In addition, Mr. Oringer is a Board Director of CanAm Care, an Access Product Marketing company, (Alpharetta, Georgia) and dLife, a LifeMed Media company (Westport, Connecticut). He is also board advisor at AgaMatrix (Salem, New Hampshire), providing guidance on marketing and business development strategies.

From 1990 through 1998, Mr. Oringer was the President of CanAm Care, a leading supplier of branded and private label diabetes care products. In 1998, he led the sale of CanAm Care to Inverness Medical. Upon the sale of CanAm Care to Inverness, Mr. Oringer joined the Board of Directors of Inverness. When Inverness Medical’s diabetes assets were sold to Johnson & Johnson in 2002, Mr. Oringer was involved in Access Product Marketing’s acquisition of CanAm Care from Johnson & Johnson.

Mr. Oringer is a graduate of the Wharton School of Finance at the University of Pennsylvania.

Dr. Pavel Hamet

Scientific Committee Chairman

Born in the Czech Republic, Dr. Hamet is the Canada Research Chair in Predictive Genomics. He works at the Centre Hospitalier de l’Université de Montréal (CHUM) where he is Chief of Genetic Medicine Services, a member of Endocrinology Services and the Director of the Laboratory of Molecular Medicine. Dr. Hamet was former Director of Research at the CHUM from 1996 to 2006. He is also a tenured professor at the Faculty of Medicine at the Université de Montréal. He serves on many national and international boards, including the Institute of Circulatory and Respiratory Health of the Canadian Institute of Health Research (CIHR).

In 1996, Dr. Hamet received the Distinguished Scientist Award from the Canadian Society for Clinical Investigation and the Canadian Cardiovascular Society’s Achievement Award. The Quebec government paid homage to Dr. Hamet in 2001 when he was awarded the Wilder-Penfield Award, the most prestigious honor in medicine in Quebec.

In 2008, he was elected Officer of the Ordre national du Québec, the most prestigious distinction awarded by the Province of Québec and received the International Okamoto Award, a prize from Japan awarded to researchers who made outstanding contributions to cardiovascular research on diseases such as hypertension, atherosclerosis and diabetes (ref: IRCM).

In May 2009 he received from the Czech and Slovak Association the Masaryk Award and in September he received a distinction award from the Russian Society of Cardiology and the Russian Antihypertensive league.

In October, 2009, the Dr. Hamet had the honour to be invited as speaker by the Canadian Society of Endocrinology and Metaolism to present the annual reading. He was also the 1st prize winner to receive from the CHUM Fondation «le Prix Hommage» to underline his life and remarkable career. Dr. Hamet has a PhD in Experimental Medicine from McGill University. He is a licensed endocrinology specialist in Quebec (CSPQ) and has been a Fellow of the Royal College of Physicians and Surgeons of Canada since 1984.

Dr. Jean-Louis Chiasson

Principal Investigator